Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 3
1995 1
1996 2
1997 3
1998 4
1999 6
2000 3
2001 6
2002 6
2003 3
2004 7
2005 7
2006 13
2007 1
2008 3
2009 4
2010 7
2011 7
2012 6
2013 13
2014 14
2015 14
2016 7
2017 14
2018 21
2019 17
2020 19
2021 26
2022 35
2023 19
2024 18
2025 22
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Results by year

Filters applied: . Clear all
Page 1
Optimization of Ki67 digital image analysis in breast cancer by automated tumor area identification.
Jank P, Krämer MJ, Untch M, Reinisch M, Link T, Grass A, Blohmer JU, Hanusch C, Litmeyer AS, Huober J, Gerber D, Solbach C, Bjelic-Radisic V, Saeger K, Schneeweiss A, Rhiem K, Gleitsmann M, von Gerlach S, Felder B, Jesinghaus M, Denkert C, Loibl S, Schmitt WD. Jank P, et al. Among authors: blohmer ju. Virchows Arch. 2026 Apr 23. doi: 10.1007/s00428-026-04500-7. Online ahead of print. Virchows Arch. 2026. PMID: 42024163
Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial.
Loibl S, Untch M, Huober J, Schaser V, Braun M, Denkert C, Hartkopf A, Blohmer JU, Hanusch C, Link T, Reinisch M, Zahm DM, Weide R, Bjelic-Radisic V, Staib P, Tesch H, Rhiem K, Lorenz R, Rey J, Schneeweiss A. Loibl S, et al. Among authors: blohmer ju. J Clin Oncol. 2026 Apr 20:JCO2502311. doi: 10.1200/JCO-25-02311. Online ahead of print. J Clin Oncol. 2026. PMID: 42008768
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer.
Van Mackelenbergh MT, Pfarr N, Weber K, Untch M, Solbach C, Schneeweiss A, Jank P, Blohmer J, Treue D, Schmatloch S, Lehmann A, Hanusch C, Link T, Sers C, Bjelic-Radisic V, Hummel M, Huober J, Schmitt WD, Fasching PA, Aktas B, Rhiem K, Reinisch M, Nekljudova V, Denkert C, Loibl S. Van Mackelenbergh MT, et al. Among authors: blohmer j. NPJ Breast Cancer. 2026 Apr 14;12(1):59. doi: 10.1038/s41523-026-00948-7. NPJ Breast Cancer. 2026. PMID: 41974716 Free PMC article.
Fertility preservation counseling in reproductive-age women with cancer.
Martin M, Sehouli J, Altmann J, Stark E, Karaman M, Busse A, von Selasinsky S, Blohmer JU, Dimitrova D. Martin M, et al. Among authors: blohmer ju. Int J Gynecol Cancer. 2026 May;36(5):104660. doi: 10.1016/j.ijgc.2026.104660. Epub 2026 Mar 20. Int J Gynecol Cancer. 2026. PMID: 41974152 Free article.
Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX).
Link T, Reinisch M, Just M, Untch M, Filmann N, Stötzer O, Denkert C, Bjelic-Radisic V, Wimberger P, Thill M, Rhiem K, Huober J, Solbach C, Hanusch C, Engels K, Fasching PA, Schneeweiss A, Nekljudova V, Holtschmidt J, Blohmer JU, Loibl S. Link T, et al. Among authors: blohmer ju. ESMO Open. 2025 Dec;10(12):105915. doi: 10.1016/j.esmoop.2025.105915. Epub 2025 Nov 27. ESMO Open. 2025. PMID: 41313969 Free PMC article. Clinical Trial.
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials.
Conforti F, Holtschmidt J, Nekljudova V, Sala I, Pagan E, Solbach C, Untch M, Denkert C, Bagnardi V, Pala L, Fasching PA, Schneeweiss A, Lück HJ, Viale G, De Pas T, van Mackelenbergh M, Huober J, Müller V, Link T, Karn T, Reinisch M, Marmé F, Bjelic-Radisic V, Schem C, Hartkopf A, Stickeler E, Hanusch C, Blohmer JU, Fehm T, Rhiem K, Gelber R, Loibl S. Conforti F, et al. Among authors: blohmer ju. Lancet Oncol. 2025 Dec;26(12):1584-1597. doi: 10.1016/S1470-2045(25)00546-7. Lancet Oncol. 2025. PMID: 41308675
Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 Trial.
Graeser M, Gluz O, Schmid P, Jóźwiak K, Zu Eulenburg C, Feuerhake F, Volk V, Ulbrich-Gebauer D, Biehl C, Reinisch M, Lüdtke-Heckenkamp K, Hartkopf A, Hilpert F, Braun M, Blohmer JU, Christgen M, Kreipe HH, Nitz U, Pelz E, Harbeck N, Kuemmel S. Graeser M, et al. Among authors: blohmer ju. Clin Cancer Res. 2026 Jan 6;32(1):214-223. doi: 10.1158/1078-0432.CCR-25-1923. Clin Cancer Res. 2026. PMID: 41182413
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.
Reimer T, Kuehn T, Mueller V, Ditsch N, Fehm T, Albert US, Bartsch R, Bauerfeind I, Bjelic-Radisic V, Blohmer JU, Budach W, Dall P, Fallenberg EM, Fasching PA, Friedrich M, Gerber B, Gluz O, Harbeck N, Hartkopf A, Heil J, Hoerner-Rieber J, Huober J, Janni W, Kreipe HH, Krug D, Kuemmel S, Loibl S, Lueftner D, Lux MP, Maass N, Mundhenke C, Park-Simon TW, Reinisch M, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schuetz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, van Mackelenbergh M, Witzel I, Woeckel A, Wuerstlein R, Banys-Paluchowski M, Thill M. Reimer T, et al. Among authors: blohmer ju. Eur J Surg Oncol. 2025 Nov;51(11):110445. doi: 10.1016/j.ejso.2025.110445. Epub 2025 Sep 17. Eur J Surg Oncol. 2025. PMID: 40983010 Free article.
300 results